The importance of recognizing thymic radioiodine uptake as the cause of a false-positive mediastinal focus in the whole-body 131I scan, done for the evaluation of post-thyroidectomy cases of differentiated thyroid carcinoma, is illustrated with the corresponding clinicoradiorological correlation. The pattern of mediastinal uptake could vary based upon the pattern of thymic hyperplasia in an individual case. Three different patterns of mediastinal uptake were observed in the cases described in the present report. Recognizing the patterns and the clinical settings (where this was to be suspected by the treating physician) was important to obviate unnecessary aggressive treatment, such as, surgery or radioiodine therapy. In a review of the literature, we found that a majority of the cases were reported in the young population (related to the thymus reaching its peak size during adolescence and gradual atrophy in the following decades) and in patients undergoing a six-month follow-up whole body diagnostic scan after thyroid remnant ablation treatment, and also in patients receiving a second course of 131-iodine treatment for a persistently elevated thyroglobulin (Tg) level. The indicators that should raise the suspicion of false-positive radioiodine uptake to the attending physician include: (a) undetectable/low serum thyroglobulin level (although this may not be always the case, depending on the clinical setting), (b) a well-controlled disease with no other abnormal focus in the rest of the body,

Download full-text PDF

Source
http://dx.doi.org/10.4103/0973-1482.143360DOI Listing

Publication Analysis

Top Keywords

differentiated thyroid
8
thyroid carcinoma
8
radioiodine uptake
8
mediastinal uptake
8
thyroglobulin level
8
uptake
5
thymus uptake
4
uptake 131i
4
131i patients
4
patients differentiated
4

Similar Publications

Objective: To evaluate the role of serum thyroglobulin (TG) as a biochemical marker for differential diagnosis of common aetiologies of hyperthyroidism.

Study Design: Comparative cross-sectional study. Place and Duration of the Study: Department of Chemical Pathology and Endocrinology, Armed Forces Institute of Pathology (AFIP), Rawalpindi, Pakistan, from October 2023 to March 2024.

View Article and Find Full Text PDF

Polycystic ovary syndrome and risk of differentiated thyroid cancer: A nationwide, register-based cohort study based on Danish health data.

Cancer Epidemiol

January 2025

Virus, Lifestyle and Genes, Danish Cancer Institute, Copenhagen, Denmark; Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. Electronic address:

Objectives: To evaluate the association between polycystic ovary syndrome (PCOS) and the risk of differentiated and papillary thyroid cancer.

Methods: We included all individuals assigned female at birth and born during 1962-1996 in Denmark. Information on vital status, PCOS- and cancer diagnoses, and covariates were attained from various Danish nationwide registers.

View Article and Find Full Text PDF

Introduction Thyroid malignancy remains a significant global health concern, making the accurate differentiation between benign and malignant thyroid nodules crucial for optimal patient management. Fine-needle aspiration cytology (FNAC) is the gold-standard preoperative diagnostic tool, and The Bethesda System for Reporting Thyroid Cytopathology provides a standardized framework for interpretation. This 10-year retrospective study evaluated the malignancy risk in surgically treated patients with thyroid nodules classified as Bethesda Category III by comparing FNAC findings with histopathological outcomes.

View Article and Find Full Text PDF

Papillary thyroid cancer (PTC) is the most frequent thyroid malignancy. Recently, the incidence has become widespread among both male and female individuals worldwide. In this article, we aim to report a 32-year-old Saudi female who presented with a painless lateral neck mass for more than seven months, and on excisional biopsy, was found to have features of PTC.

View Article and Find Full Text PDF

Background: With rising well-differentiated thyroid cancer (WDTC) incidence, the appropriate treatment choice remains controversial for T1 tumors <2 cm. This study analyzed differences in surgery refusal and survival outcomes between T1a (<1 cm) and T1b (1-2 cm) WDTC, examining the demographic and clinical characteristics associated with patients who decide to either undergo or refuse recommended surgery.

Methods: We studied 81,664 T1N0M0 WDTC patients in the Surveillance, Epidemiology, and End Results (SEER) registry [2000-2019].

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!